We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
Cap. Flow
+$33.3M
Cap. Flow %
18.49%
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.54M
2
CHRS icon
Coherus Oncology
CHRS
+$3.29M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$2.71M
4
EMBC icon
Embecta
EMBC
+$2.55M
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.33M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$4.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.81M
3
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$2.81M
4
INVA icon
Innoviva
INVA
+$2.07M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 59.9%
2 Real Estate 10.66%
3 Financials 4.01%
4 Technology 3.46%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
251
Marvell Technology
MRVL
$174B
– –
-901
Closed -$39K
NMCO icon
252
Nuveen Municipal Credit Opportunities Fund
NMCO
$579M
– –
-6,550
Closed -$74.7K
NMZ icon
253
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
– –
-8,100
Closed -$87.5K
NNOX icon
254
Nano X Imaging
NNOX
$62.4M
– –
-35,000
Closed -$202K
NUE icon
255
Nucor
NUE
$56.4B
– –
-1,851
Closed -$286K
NUVL
256
DELISTED
Nuvalent
NUVL
– –
-17,897
Closed -$467K
NVAX icon
257
Novavax
NVAX
$1.23B
– –
-150,000
Closed -$1.04M
PEP icon
258
PepsiCo
PEP
$186B
– –
-1,469
Closed -$268K
PMF
259
DELISTED
PIMCO Municipal Income Fund
PMF
– –
-10,000
Closed -$99.5K
PMM
260
Franklin Managed Municipal Income Trust
PMM
$275M
– –
-16,500
Closed -$101K
PMO
261
Franklin Municipal Opportunities Trust
PMO
$282M
– –
-4,820
Closed -$49.9K
PMX
262
DELISTED
PIMCO Municipal Income Fund III
PMX
– –
-5,000
Closed -$41.5K
QQQ icon
263
Invesco QQQ Trust
QQQ
$455B
– –
-8,749
Closed -$2.81M
QQQM icon
264
Invesco NASDAQ 100 ETF
QQQM
$95.1B
– –
-21,262
Closed -$2.81M
RSG icon
265
Republic Services
RSG
$66.7B
– –
-1,933
Closed -$261K
SNY icon
266
Sanofi
SNY
$104B
– –
-10,000
Closed -$544K
STLD icon
267
Steel Dynamics
STLD
$35.6B
– –
-1,413
Closed -$160K
TECK icon
268
Teck Resources
TECK
$29.5B
– –
-4,208
Closed -$154K
THD icon
269
iShares MSCI Thailand ETF
THD
$361M
– –
-323
Closed -$23.7K
TRV icon
270
Travelers Companies
TRV
$80.8B
– –
-720
Closed -$123K
TSN icon
271
Tyson Foods
TSN
$20.2B
– –
-1,399
Closed -$83K
TVTX icon
272
Travere Therapeutics
TVTX
$5.33B
– –
-19,640
Closed -$442K
UNH icon
273
UnitedHealth
UNH
$382B
– –
-520
Closed -$246K
WLK icon
274
Westlake Corp
WLK
$9.46B
– –
-801
Closed -$92.9K
WRB icon
275
W.R. Berkley
WRB
$28B
– –
-5,685
Closed -$236K
8 9 10
11
12

Similar funds

AIS
Advocate Investing Services Woodbine, Maryland $118M AUM
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $118M AUM 64.91% 1-Year Est. Return
OIM
Oceanic Investment Management Douglas, Isle Of Man $118M AUM
TIP
Tandem Investment Partners Bordentown, New Jersey $118M AUM 15.76% 1-Year Est. Return
RCG
Ridge Creek Global Strongsville, Ohio $118M AUM
CWM
Capstone Wealth Management Billings, Montana $118M AUM
SPW
Stillwater Private Wealth Glen Mills, Pennsylvania $118M AUM
WLC
Walnut Level Capital Denver, Colorado $118M AUM 59.12% 1-Year Est. Return

AlphaCentric Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.

  • AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
  • AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
  • AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
  • AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
  • AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.

Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.